Literature DB >> 2513780

Oral plasma zinc tolerance test in patients with protein energy malnutrition.

Y Atalay1, A Arcasoy, M Kürkçüoğlu.   

Abstract

Zinc absorption was measured in 37 children with malnutrition using the oral zinc tolerance test (22.5 mg elementary zinc) and the results compared with those of a group of healthy control subjects. The increase in plasma zinc was significantly lower in patients with marasmic kwashiorkor than in the control group. The zinc tolerance test was, however, normal in marasmic patients. We conclude that zinc deficiency occurs in some types of protein energy malnutrition, and that malabsorption may aggravate zinc deficiency. It is reasonable to give higher doses of zinc than are usually recommended during oral zinc supplementation in patients with protein energy malnutrition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513780      PMCID: PMC1792640          DOI: 10.1136/adc.64.11.1608

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  A simple scoring system for classifying the severe forms of protein-calorie malnutrition of early childhood.

Authors:  D S McLaren; P L Pellett; W W Read
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

2.  Erythrocyte and plasma zinc and magnesium levels in health and disease.

Authors:  F Rosner; P C Gorfien
Journal:  J Lab Clin Med       Date:  1968-08

3.  Jejunal mucosa in infant malnutrition.

Authors:  O Brunser; A Reid; F Monckeberg; A Maccioni; I Contreras
Journal:  Am J Clin Nutr       Date:  1968-09       Impact factor: 7.045

4.  Zinc-dependent enzymes in zinc-depleted rats; intestinal alkaline phosphatase.

Authors:  J G Reinhold; G A Kfoury
Journal:  Am J Clin Nutr       Date:  1969-09       Impact factor: 7.045

5.  Does the oral zinc tolerance test measure zinc absorption?

Authors:  L S Valberg; P R Flanagan; J Brennan; M J Chamberlain
Journal:  Am J Clin Nutr       Date:  1985-01       Impact factor: 7.045

6.  Serum alkaline phosphatase activity in acrodermatitis enteropathica: an index of the serum zinc level.

Authors:  K Weismann; H Høyer
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

7.  A zinc tolerance test.

Authors:  J F Sullivan; M M Jetton; R E Burch
Journal:  J Lab Clin Med       Date:  1979-03

8.  Plasma and erythrocyte zinc levels in protein-calorie malnutrition.

Authors:  S Kumar; K S Rao
Journal:  Nutr Metab       Date:  1973       Impact factor: 4.169

9.  Plasma zinc and the clinical features of malnutrition.

Authors:  B E Golden; M H Golden
Journal:  Am J Clin Nutr       Date:  1979-12       Impact factor: 7.045

10.  Reversible intestinal mucosal abnormality in acrodermatitis enteropathica.

Authors:  R Kelly; G P Davidson; R R Townley; P E Campbell
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

View more
  3 in total

1.  Pharmacokinetic study of orally administered zinc in humans: evidence for an enteral recirculation.

Authors:  J Nève; M Hanocq; A Peretz; F Abi Khalil; F Pelen; J P Famaey; J Fontaine
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

2.  Infusion of zinc inhibits serum calcitonin levels in patients with various zinc status.

Authors:  S Nishiyama; T Nakamura; A Higashi; I Matsuda
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

Review 3.  Zinc: health effects and research priorities for the 1990s.

Authors:  C T Walsh; H H Sandstead; A S Prasad; P M Newberne; P J Fraker
Journal:  Environ Health Perspect       Date:  1994-06       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.